Salivary Bmp-2 Levels & Radiographic Measurement Of Bone Density at Extracted Tooth (salivaryBMP2)

May 5, 2022 updated by: Muhammad Mutahir Mehdi, Postgraduate Medical Institute, Lahore

Salivary Bmp-2 Levels And Radiographic Measurement Of Bone Density At Extracted Tooth Socket In Patients With And Without Topical Application Of Simvastatin

Salivary Bmp-2 Levels & Radiographic Measurement Of Bone Density were evaluated At Extracted Tooth Socket in patients With & Without topical Application Of Simvastatin

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Objective: The objective of this study was to compare:

'The salivary BMP-2 levels in the experimental and the control groups with and without topical simvastatin application on wound of extracted tooth socket.

The bone density at extracted tooth socket by measuring mean gray value from Intra oral periapical (IOPA) radiographs in the experimental and the control groups.

Method: Twenty four patients either male or female without any systemic disease, aged between 18 years to 25 years were selected. The patients were equally divided by random computer generated numbers into experimental and control groups. In the experimental group, tooth extraction was followed by placement of simvastatin (containing 10 mg of drug). In the control group, only tooth extraction was done. Saliva sample was collected from patients on days 0, 3, 7 and 40 and levels of salivary biomarker BMP-2 were measured with the ELISA technique. IOPA radiographs were taken on days 0 and 40 to determine the bone density by measuring mean gray values with the help of ImageJ software. The data was entered in SPSS version 25 and analyzed. P-value of ≤ 0.05 was considered as statistically significant.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Lahore, Punjab, Pakistan
        • Dental Department of Lahore General Hospital.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Both male and female patients with permanent dentition, age (18 years to 25 years) were considered.
  • Patients undergoing extraction of maxillary or mandibular Pre molars for orthodontic procedure.
  • Teeth which required only simple non surgical extraction only under local anesthesia.

Exclusion Criteria:

  • Subjects taking antibiotics or non-steroidal anti inflammatory drugs (NSAIDS) within one week.
  • Patients with oral mucosal lesions (leukoplakia, erythroplakia, lichen planus).
  • Patients with oral carcinoma.
  • Patients with xerostomia.
  • Previous history of radiotherapy or chemotherapy
  • Patient with known hypersensitivity to anti inflammatory drugs.
  • Diabetic patients.
  • Pregnant and lactating patients.
  • Patients with social habits such as cigarette smoking and alcohol consumption.
  • Teeth radiographically involved in any abscess/cyst/granuloma.
  • Teeth requiring open surgical transalveolar extraction.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Placebo
Atraumatic Extraction Only (placement of gelatin sponge mixed with normal saline without SIMVASTATIN).
Experimental: Simvastatin
Atraumatic Extraction and administration of SIMVASTATIN (10 mg tablet grounded and added with normal saline, with gelatin sponge as a transporter) into the socket.
Atraumatic Extraction and administration of SIM (10 mg tablet grounded and added with normal saline, with gelatin sponge as a transporter) into the socket to observe alveolar bone healing.
Other Names:
  • SIM

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Salivary BMP-2 Levels
Time Frame: At start of study
Mean values were measured using ELISA technique
At start of study
Salivary BMP-2 Levels
Time Frame: At 3rd day Of Study
Mean values were measured using ELISA technique
At 3rd day Of Study
Salivary BMP-2 Levels
Time Frame: At 10th Day of study
Mean values were measured using ELISA technique
At 10th Day of study
Salivary BMP-2 Levels
Time Frame: At 40th Day of study
Mean values were measured using ELISA technique
At 40th Day of study
Bone Density
Time Frame: At start of study
Mean grey value were measured using imageJ software
At start of study
Bone Density
Time Frame: At 40th day of study
Mean grey value were measured using imageJ software
At 40th day of study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: shagufta nasreen, Pgmi. Lahore

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 16, 2020

Primary Completion (Actual)

October 3, 2021

Study Completion (Actual)

January 5, 2022

Study Registration Dates

First Submitted

March 29, 2022

First Submitted That Met QC Criteria

May 5, 2022

First Posted (Actual)

May 11, 2022

Study Record Updates

Last Update Posted (Actual)

May 11, 2022

Last Update Submitted That Met QC Criteria

May 5, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bone Injury

Clinical Trials on Simvastatin 10mg

Subscribe